Abstract: Objective: To explore the effect of salt-processing technology on oligosaccharides of Morindae Officinalis Radix,and to analyze the potential mechanism of salt-processed Morindae Officinalis Radix in ameliorating Alzheimer's disease (AD) based on network pharmacology and molecular docking. Methods:Uniform design method was adopted to optimize the salt-processing parameters of Morindae Officinalis Radix. HPLC-ELSD was used to detect the changes of oligosaccharides before and after processing. Active ingredient targets of Morindae Officinalis Radix were retrieved from TCMSP, SwissTargetPrediction, and SuperPred databases. AD-related targets were collected from OMIM,TTD,Harmonizome,GeneCards,DisGeNET,and GEO datasets. STRING database and Cytoscape software were applied to screen core targets. DAVID database was used for GO functional annotation and KEGG pathway enrichment analyses. CB-dock2 was employed for preliminary molecular docking verification. Results:The optimized salt-processing technology yielded salt-processed Morindae Officinalis Radix with the highest nystose content. After salt processing, fructose content increased,while the levels of oligosaccharides including sucrose,kestose,nystose ,and fructopentaose decreased. A total of 35 intersecting targets were obtained, which mainly involved PI3K-Akt, IL-17, and MAPK signaling pathways. Molecular docking results demonstrated that ursolic acid,β-sitosterol,and physcion possessed strong binding activity with PTGS2, MET, and GSK3B. Conclusion: This study determines the optimal salt-processing parameters and clarifies its influence on oligosaccharides of salt-processing technology of Morindae Officinalis Radix. Salt processing elevates the contents of triterpenoids,sterols,and anthraquinones including ursolic acid,β-sitosterol,and physcion,and alters oligosaccharides profiles. Multiple ingredients synergistically act on ADrelated targets, regulating PI3K-Akt pathway, restraining neuroinflammation, modulating cholinergic system and resisting cell apoptosis,so as to improve pathological conditions of AD.